Font Size:
a
A
A
Keyword [unstable angina pectoris]
Result: 161 - 180 | Page: 9 of 10
161.
The Relationship Among The Changes Of Ischemia Modified Albumin, Homocystein And TCM Syndrome Of Patients With Unstable Angina Pectoris
162.
The Clinical Research Of CD40L On The Treatment Of Xiongbitie-â… For Unstable Angina Pectoris
163.
Effect Of Salvianola On The Level Of Platelet Aggre Gation Function, Plasma Fibrinogen And Homocysteine In Patiens With Unstable Angina Pectoris
164.
Clinical Curative Effects Observation Of The Treatment Of Unstable Angina With Acupoints Application Of Chest-Bi-Stick1
165.
The Effect Of Jiaweisuanzaorentang On Interleukin-17 In Unstable Angina Pectoris With Depressiive State
166.
The Influence Of Jiaweihuanglianwendan Decoction On Homocysteine Levels In The Patients With Phl Egm-Heat Stasis Type Unstable Angina Pectoris In Coronary Heart Disease
167.
Effects Of Xiong Bipian On Homocysteine In Phlegm And Blood Stasis Type Unstable Angina Pectoris Patients
168.
Fasudil On Unstable Angina Pectoris, C-Reactive Protein, Endothelin, Endothelin, Nitric Oxide
169.
Relatinship Of The Small, Dense Low-density Lipoprotein With Coronary Heart Disease And The Stenosis Of Coronary Arteries
170.
The Clinical Efficacy And Safety Evaluation Of The Rho-kinase Inhibitor-fasudil Hydrochloride,in Patients With Unstable Angina
171.
Heart Type Fatty Acid Binding Protein In Patients With Acute Coronary Syndrome Research Progress
172.
The Relationship Between Platelet MiR-223and MiR-96Expression And Clopidogrel Response In Patients With Coronary Artery Disease
173.
The Study Of The Relationship Between Plasma Omentin-1,IL-18, IL-16Levels And Coronary Heart Disease
174.
Myocardial Protective Effect Of Danhong Injection Evaluated By Velocity Vector Imaging In Patients With Unstable Angina Pectoris After Percutaneous Coronary Intervention
175.
Clinical Significance Of MiR-146a-5p In Unstable Angina Pectoris And Its Inflammatory Inhibition Roles In Cholesterol Metabolism
176.
Prognostic Effects Of Atorvastatin At Different Dosages On Percutaneous Coronary Intervention Among Patients With Unstable Angina Pectoris
177.
The Characteristics Of Metabonomics And The Change After Drug And Intervention Therapy In Patients With Unstable Angina Pectoris
178.
The Myocardial Protective Effect Of Nocorandil On Patients With Unstable Angina Pectoris After Percutaneous Coronary Intervention Therapy
179.
Effects Of Kangshuan No.1in Patients With Unstable Angina Pectoris And Its Influences On Endothelin-1and Thromboxane B
2
Levels
180.
The Association Between The Blood Stasis Score Of Tradition Chinese Medicine And TIMI Risk Stratification On Patients With Unstable Angina Pectoris
<<First
<Prev
Next>
Last>>
Jump to